87 related articles for article (PubMed ID: 19814753)
1. Low frequency of VHL germline mutations in Norwegian patients presenting with isolated central nervous system hemangioblastomas--a population-based study.
Rønning P; Andresen PA; Hald JK; Heimdal K; Scheie D; Schreiner T; Helseth E
Acta Neurol Scand; 2010 Aug; 122(2):124-31. PubMed ID: 19814753
[TBL] [Abstract][Full Text] [Related]
2. [Von Hippel-Lindau disease and central nervous system hemangioblastoma. Progress in genetics and clinical management].
Richard S; Martin S; David P; Decq P
Neurochirurgie; 1998 Nov; 44(4):258-66. PubMed ID: 9864697
[TBL] [Abstract][Full Text] [Related]
3. [Does hemangioblastoma exist outside von Hippel-Lindau disease?].
Richard S; Beigelman C; Gerber S; Van Effenterre R; Gaudric A; Sahel M; Binaghi M; De Kersaint-Gilly A; Houtteville JP; Brunon JP
Neurochirurgie; 1994; 40(3):145-54. PubMed ID: 7723921
[TBL] [Abstract][Full Text] [Related]
4. Cryptic von Hippel-Lindau disease: germline mutations in patients with haemangioblastoma only.
Hes FJ; McKee S; Taphoorn MJ; Rehal P; van Der Luijt RB; McMahon R; van Der Smagt JJ; Dow D; Zewald RA; Whittaker J; Lips CJ; MacDonald F; Pearson PL; Maher ER
J Med Genet; 2000 Dec; 37(12):939-43. PubMed ID: 11106358
[TBL] [Abstract][Full Text] [Related]
5. Investigation and Management of Apparently Sporadic Central Nervous System Haemangioblastoma for Evidence of Von Hippel-Lindau Disease.
Furness H; Salfity L; Devereux J; Halliday D; Hanson H; Ruddy DM; Uk Vhl Study Group ; Shah N; Sultana G; Woodward ER; Sandford RN; Snape KM; Maher ER
Genes (Basel); 2021 Sep; 12(9):. PubMed ID: 34573396
[TBL] [Abstract][Full Text] [Related]
6. [Hemangioblastomas of the central nervous system in Camagüey (Cuba)].
Vega-Basulto S; Silva-Adán S; Peñones-Montero R; Mosqueda-Betancourt G
Rev Neurol; 2002 Sep 16-30; 35(6):512-6. PubMed ID: 12389165
[TBL] [Abstract][Full Text] [Related]
7. Von Hippel-Lindau disease germline mutations in Mexican patients with cerebellar hemangioblastoma.
Rasmussen A; Nava-Salazar S; Yescas P; Alonso E; Revuelta R; Ortiz I; Canizales-Quinteros S; Tusié-Luna MT; López-López M
J Neurosurg; 2006 Mar; 104(3):389-94. PubMed ID: 16572651
[TBL] [Abstract][Full Text] [Related]
8. Molecularly genetic analysis of von Hippel-Lindau associated central nervous system hemangioblastoma.
Zhou J; Wang J; Li N; Zhang X; Zhou H; Zhang R; Ma H; Zhou X
Pathol Int; 2010 Jun; 60(6):452-8. PubMed ID: 20518900
[TBL] [Abstract][Full Text] [Related]
9. Frequency of Von Hippel-Lindau germline mutations in classic and non-classic Von Hippel-Lindau disease identified by DNA sequencing, Southern blot analysis and multiplex ligation-dependent probe amplification.
Hes FJ; van der Luijt RB; Janssen AL; Zewald RA; de Jong GJ; Lenders JW; Links TP; Luyten GP; Sijmons RH; Eussen HJ; Halley DJ; Lips CJ; Pearson PL; van den Ouweland AM; Majoor-Krakauer DF
Clin Genet; 2007 Aug; 72(2):122-9. PubMed ID: 17661816
[TBL] [Abstract][Full Text] [Related]
10. VHL mutation analysis in patients with isolated central nervous system haemangioblastoma.
Woodward ER; Wall K; Forsyth J; Macdonald F; Maher ER
Brain; 2007 Mar; 130(Pt 3):836-42. PubMed ID: 17264095
[TBL] [Abstract][Full Text] [Related]
11. Hemangioblastomas of central nervous system: molecular genetic analysis and clinical management.
Catapano D; Muscarella LA; Guarnieri V; Zelante L; D'Angelo VA; D'Agruma L
Neurosurgery; 2005 Jun; 56(6):1215-21; discussion 1221. PubMed ID: 15918937
[TBL] [Abstract][Full Text] [Related]
12. Somatic mutations in VHL germline deletion kindred correlate with mild phenotype.
Wait SD; Vortmeyer AO; Lonser RR; Chang DT; Finn MA; Bhowmick DA; Pack SD; Oldfield EH; Zhuang Z
Ann Neurol; 2004 Feb; 55(2):236-40. PubMed ID: 14755727
[TBL] [Abstract][Full Text] [Related]
13. Central nervous system hemangioblastomas, endolymphatic sac tumors, and von Hippel-Lindau disease.
Richard S; David P; Marsot-Dupuch K; Giraud S; Béroud C; Resche F
Neurosurg Rev; 2000 Mar; 23(1):1-22; discussion 23-4. PubMed ID: 10809480
[TBL] [Abstract][Full Text] [Related]
14. Intronic mutation of the VHL gene associated with central nervous system hemangioblastomas in two Chinese families with Von Hippel-Lindau disease: case report.
Liu Z; Zhou J; Li L; Yi Z; Lu R; Li C; Gong K
BMC Med Genet; 2020 Oct; 21(1):191. PubMed ID: 33004005
[TBL] [Abstract][Full Text] [Related]
15. Somatic mutations of the von Hippel-Lindau tumor suppressor gene in sporadic central nervous system hemangioblastomas.
Kanno H; Kondo K; Ito S; Yamamoto I; Fujii S; Torigoe S; Sakai N; Hosaka M; Shuin T; Yao M
Cancer Res; 1994 Sep; 54(18):4845-7. PubMed ID: 8069849
[TBL] [Abstract][Full Text] [Related]
16. Germline mutations in the von Hippel-Lindau disease tumor suppressor gene: correlations with phenotype.
Chen F; Kishida T; Yao M; Hustad T; Glavac D; Dean M; Gnarra JR; Orcutt ML; Duh FM; Glenn G
Hum Mutat; 1995; 5(1):66-75. PubMed ID: 7728151
[TBL] [Abstract][Full Text] [Related]
17. Surveillance in von Hippel-Lindau disease (vHL).
Poulsen ML; Budtz-Jørgensen E; Bisgaard ML
Clin Genet; 2010 Jan; 77(1):49-59. PubMed ID: 19863552
[TBL] [Abstract][Full Text] [Related]
18. Clinical characteristics of ocular angiomatosis in von Hippel-Lindau disease and correlation with germline mutation.
Webster AR; Maher ER; Moore AT
Arch Ophthalmol; 1999 Mar; 117(3):371-8. PubMed ID: 10088816
[TBL] [Abstract][Full Text] [Related]
19. Multifocal bilateral renal cell carcinoma and retinal angiomas in a patient with de novo von Hippel-Lindau disease: identification of a new germline mutation.
Sessa A; Battini G; Meroni M; Pitingolo F; Righetti M; Ciotti P; Di Maria E; Bellone E; Ajmar F; Mandich P
J Nephrol; 2005; 18(2):209-12. PubMed ID: 15931650
[TBL] [Abstract][Full Text] [Related]
20. Incidence of von Hippel-Lindau disease in hemangioblastoma patients: the University of Tokyo Hospital experience from 1954-1998.
Sora S; Ueki K; Saito N; Kawahara N; Shitara N; Kirino T
Acta Neurochir (Wien); 2001 Sep; 143(9):893-6. PubMed ID: 11685621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
